Guidance in Topic selection
Showing 1 to 2 of 2
Title | Technology type | Decision |
---|---|---|
MMprofiler for prognostic risk classification in multiple myeloma (MT623) (MIB270) | Diagnostic | Not selected |
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments TSID 11969 | Medicine | Not selected |